Healthcare provider profile · identity verified

Randy L Stewart, M.D.

Internal Medicine · CLAUDE, TX · NPI 1841262003

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	397	71
Potassium Chloride	Potassium Chloride	251	68
Levothyroxine Sodium	Levothyroxine Sodium	244	56
Atorvastatin Calcium	Atorvastatin Calcium	225	50
Furosemide	Furosemide	221	65
Tramadol Hcl	Tramadol Hcl	197	64
Lisinopril	Lisinopril	182	48
Gabapentin	Gabapentin	181	50
Duloxetine Hcl	Duloxetine Hcl	157	34
Donepezil Hcl	Donepezil Hcl	142	26
Amlodipine Besylate	Amlodipine Besylate	129	34
Methadone Hcl	Methadone Hcl	128	28
Pregabalin	Pregabalin	125	24
Carvedilol	Carvedilol	122	33
Omeprazole	Omeprazole	121	35
Eliquis	Apixaban	116	21
Pantoprazole Sodium	Pantoprazole Sodium	113	36
Metoprolol Tartrate	Metoprolol Tartrate	97	24
Trazodone Hcl	Trazodone Hcl	95	28
Acetaminophen-Codeine	Acetaminophen With Codeine	92	24
Alprazolam	Alprazolam	91	19
Mirtazapine	Mirtazapine	91	23
Baclofen	Baclofen	84	18
Quetiapine Fumarate	Quetiapine Fumarate	75	21
Metformin Hcl	Metformin Hcl	72	18
Oxybutynin Chloride	Oxybutynin Chloride	71	16
Clopidogrel	Clopidogrel Bisulfate	70	19
Simvastatin	Simvastatin	67	13
Azithromycin	Azithromycin	64	45
Prednisone	Prednisone	63	24
Escitalopram Oxalate	Escitalopram Oxalate	61	19
Memantine Hcl	Memantine Hcl	61	12
Montelukast Sodium	Montelukast Sodium	57	21
Morphine Sulfate	Morphine Sulfate	57	15
Lorazepam	Lorazepam	56	21
Fluticasone Propionate	Fluticasone Propionate	55	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	55	38
Losartan Potassium	Losartan Potassium	54	19
Nystatin	Nystatin	53	29
Cephalexin	Cephalexin	50	42
Tizanidine Hcl	Tizanidine Hcl	50	11
Allopurinol	Allopurinol	48	15
Metoprolol Succinate	Metoprolol Succinate	48	13
Clonazepam	Clonazepam	47	11
Sertraline Hcl	Sertraline Hcl	45	13
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	43	15
Ondansetron Odt	Ondansetron	41	21
Tamsulosin Hcl	Tamsulosin Hcl	41	14
Doxycycline Hyclate	Doxycycline Hyclate	40	33
Hydrochlorothiazide	Hydrochlorothiazide	38	14
Levetiracetam	Levetiracetam	38	suppressed
Alendronate Sodium	Alendronate Sodium	37	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	36	19
Methocarbamol	Methocarbamol	35	19
Rosuvastatin Calcium	Rosuvastatin Calcium	35	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	34	16
Divalproex Sodium	Divalproex Sodium	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	11
Mounjaro	Tirzepatide	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	33	23
Spironolactone	Spironolactone	33	14
Fluconazole	Fluconazole	32	23
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	23
Lactulose	Lactulose	29	14
Sulfasalazine	Sulfasalazine	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	14
Methylprednisolone	Methylprednisolone	27	26
Celecoxib	Celecoxib	26	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	25	suppressed
Trintellix	Vortioxetine Hydrobromide	25	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	18
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Glipizide	Glipizide	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Metolazone	Metolazone	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Topiramate	Topiramate	21	suppressed
Folic Acid	Folic Acid	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Temazepam	Temazepam	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Diazepam	Diazepam	18	suppressed
Famotidine	Famotidine	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Mupirocin	Mupirocin	18	13
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	11
Cefuroxime	Cefuroxime Axetil	16	15
Olanzapine	Olanzapine	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Memantine Hcl Er	Memantine Hcl	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Haloperidol	Haloperidol	14	suppressed
Levofloxacin	Levofloxacin	14	12
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Nystop	Nystatin	14	12
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	12	suppressed
Finasteride	Finasteride	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Methimazole	Methimazole	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Risperidone	Risperidone	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lubiprostone	Lubiprostone	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error